These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4376512)

  • 1. The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells.
    Bomford R; Olivotto M
    Int J Cancer; 1974 Aug; 14(2):226-35. PubMed ID: 4376512
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.
    McBride WH; Tuach S; Marmion BP
    Br J Cancer; 1975 Nov; 32(5):558-67. PubMed ID: 813755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Inhibition of immunization with irradiated tumour cells by a large dose of Corynebacterium parvum.
    Woodruff M; Whitehead VL
    Proc R Soc Lond B Biol Sci; 1977 Jul; 197(1129):505-14. PubMed ID: 18742
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation response of C3H fibrosarcoma enhanced in mice stimulated by Corynebacterium parvum.
    Suit HD; Sedlacek R; Wagner M; Orsi L
    Nature; 1975 Jun; 255(5508):493-4. PubMed ID: 1138200
    [No Abstract]   [Full Text] [Related]  

  • 8. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
    James K; Willmott N; Milne I; McBride WH
    J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour effects of Corynebacterium parvum in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):121-7. PubMed ID: 4435007
    [No Abstract]   [Full Text] [Related]  

  • 12. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the antitumour activities of glucans and C. parvum.
    Bomford R; Moreno C
    Dev Biol Stand; 1977 Apr 13-15; 38():291-5. PubMed ID: 608513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
    Woodruff MF; Dunbar N
    Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
    Keller R
    J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 17. A role for T lymphocytes in tumour inhibition and enhancement caused by systemic administration of Corynebacterium parvum.
    Peters LJ; McBride WH; Mason KA; Milas L
    J Reticuloendothel Soc; 1978 Jul; 24(1):9-18. PubMed ID: 308542
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of metastatic potential in a murine fibrosarcoma line by exposure to Corynebacterium parvum-elicited macrophages; effect of eicosanoid biosynthesis inhibition.
    Cecconi O; Mugnai G; Ruggieri S
    Adv Exp Med Biol; 1997; 400B():731-9. PubMed ID: 9547624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.